Literature DB >> 2149956

Derangement of non-specific immunity in Down syndrome subjects: low leukocyte chemiluminescence activity after phagocytic activation.

F Licastro1, C Melotti, R Parente, L J Davis, M Chiricolo, M Zannotti, F Barboni.   

Abstract

Metabolic activation of peripheral blood leukocytes (chemiluminescence) from 27 children with Down syndrome (DS) and 23 age and sex-matched control children after phagocytic stimulation by opsonized zymosan particles was investigated through a chemiluminescence assay. Using autologous plasma or serum as opsonizing media, phagocytic activity of circulating leukocytes was significantly decreased in DS subjects. A further decrease of phagocytic activity was found in neutrophils from DS children, when normal heterologous plasma or sera were used. On the other hand, sera or plasma from DS subjects significantly increased phagocytic activation of leukocytes from normal donors. In DS subjects opsonizing agents such as serum immunoglobulins and complement fractions were in the normal ranges of concentration. Thus, the impaired chemiluminescence of neutrophils was mainly due to a metabolic impairment at the cellular level. A decreased production of radicals derived from the oxygen metabolism in neutrophils may be an important step of immune derangement leading to the increased incidence of infectious diseases frequently associated with DS.

Entities:  

Mesh:

Year:  1990        PMID: 2149956     DOI: 10.1002/ajmg.1320370749

Source DB:  PubMed          Journal:  Am J Med Genet Suppl        ISSN: 1040-3787


  2 in total

1.  Altered endotoxin responsiveness in healthy children with Down syndrome.

Authors:  Dean Huggard; Fiona McGrane; Niamh Lagan; Edna Roche; Joanne Balfe; Timothy Ronan Leahy; Orla Franklin; Ana Moreno; Ashanty M Melo; Derek G Doherty; Eleanor J Molloy
Journal:  BMC Immunol       Date:  2018-11-03       Impact factor: 3.615

2.  Phenotype of apoptotic lymphocytes in children with Down syndrome.

Authors:  Solaf M Elsayed; Ghada M Elsayed
Journal:  Immun Ageing       Date:  2009-03-06       Impact factor: 6.400

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.